RAS also promotes the evasion of cancer cells from the immune system by stabilizing the mRNA of PD-L1(programmed cell death ligand 1) in a MEK (mitogen-activated protein kinase kinase)-dependent manner through downregulation of tristetraprolin (TTP/ZFP36), which binds and degrades mRNA [37]. This evidence concerns the gene ZFP36 and cancer.